sprint trial visual abstract on standard versus intensive blood pressure control

The SPRINT trial study was an important leap towards tighter blood pressure control in patients who had a history of cardiovascular disease and were at high risk of recurrent event but with no history of stroke or diabetes.

Guidelines update based on SPRINT trial

The 2017 ACC/AHA update on hypertension recommended:

For patients with Stable coronary artery disease – Treat to BP goal <130/80 mm Hg (COR I, LOE B-R for SBP and C-EO for DBP)

Use antihypertensive medications if prior clinical CVD or 10-year ASCVD risk score is ≥10% and BP is ≥130/≥80 mm Hg (COR I, LOE A for SBP and C-EO for DBP)

Source: NEJM,

ACC